These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 35902966)
1. Recurrent squamous cell carcinoma and a novel mutation in a patient with xeroderma pigmentosum: a case report. Şahin EA; Taşkıran EZ; Kiper PÖŞ; Aydın B; Utine E J Med Case Rep; 2022 Jul; 16(1):306. PubMed ID: 35902966 [TBL] [Abstract][Full Text] [Related]
2. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C. Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428 [TBL] [Abstract][Full Text] [Related]
3. Lung adenocarcinoma concomitant with xeroderma pigmentosum: a case report. Matsumoto M; Kaneshiro K; Takatsuki K J Med Case Rep; 2021 Mar; 15(1):160. PubMed ID: 33781316 [TBL] [Abstract][Full Text] [Related]
4. A novel XPA splice-site mutation identified in a 4-year-old Filipino girl with xeroderma pigmentosum. Reyes HH; Lin YC; Hsu CK; Guevara BEK Australas J Dermatol; 2023 May; 64(2):e165-e167. PubMed ID: 36866916 [TBL] [Abstract][Full Text] [Related]
5. A case of lip squamous cell carcinoma with a familial history of Xeroderma pigmentosum. Dartaha R; Benmelouka AY; Jobran AWM Oral Oncol; 2020 Dec; 111():104896. PubMed ID: 32654871 [TBL] [Abstract][Full Text] [Related]
6. Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum. Gilbar PJ; Pokharel K J Oncol Pharm Pract; 2022 Mar; 28(2):466-470. PubMed ID: 34647821 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family. Ali MZ; Blatterer J; Khan MA; Schaflinger E; Petek E; Ahmad S; Khan E; Windpassinger C Mol Genet Genomic Med; 2020 Feb; 8(2):e1060. PubMed ID: 31923348 [TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum: a case report and review of the literature. Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of non-melanoma skin cancer in three patients with Xeroderma Pigmentosum by modified ALA-PDT. Zheng J; Liu W; Zhou Z; Cao Z; Zhao Z; Wang X; Li M; Zhang G Photodiagnosis Photodyn Ther; 2023 Sep; 43():103694. PubMed ID: 37422200 [TBL] [Abstract][Full Text] [Related]
10. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum. Grampurohit VU; Dinesh US; Rao R J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal. Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624 [TBL] [Abstract][Full Text] [Related]
12. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life. Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128 [TBL] [Abstract][Full Text] [Related]
14. [Multiple facial squamous cell carcinomas in a child, revealing a xeroderma pigmentosum]. Beogo R; Andonaba JB; Bouletreau P; Traore Sawadogo H; Traore A Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):50-2. PubMed ID: 22056175 [TBL] [Abstract][Full Text] [Related]
15. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439 [TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab. Rubió Casadevall J; Graña-Suárez B; Hernandez-Yagüe X; Vayreda Ribera J; Huc Grasa O; Brunet Vidal J Eur J Dermatol; 2009; 19(2):163-5. PubMed ID: 19106040 [TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for squamous cell cancer of the skin in a patient with xeroderma pigmentosum. Altinok P; Tekçe E; Ergün SS; Mayadagli A J Cancer Res Ther; 2022; 18(3):801-803. PubMed ID: 35900561 [TBL] [Abstract][Full Text] [Related]
18. [Xeroderma pigmentosum]. Stary A; Sarasin A Presse Med; 1997 Dec; 26(40):1992-7. PubMed ID: 9537004 [TBL] [Abstract][Full Text] [Related]
19. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294 [TBL] [Abstract][Full Text] [Related]
20. Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum. Wei CC; Sanfilippo NJ; Myssiorek D Curr Oncol; 2010 Jun; 17(3):83-5. PubMed ID: 20567629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]